DGX
Quest Diagnostics Incorporated
Stock
$233.33+2.24 (+0.97%)Close Oct 2, 2026
- Selling, general and administrative, 2025
- $2.0B
- YoY, 2025
- +11.1%
- 5-year CAGR
- +4.9%
- 10-year CAGR
- +1.6%
Selling, general and administrative
Selling, general and administrative by fiscal year
| Period | SG&A | YoY |
|---|---|---|
| 2025 | $2.0B | +11.1% |
| 2024 | $1.8B | +7.8% |
| 2023 | $1.6B | −12.4% |
| 2022 | $1.9B | +8.5% |
| 2021 | $1.7B | +11.4% |
| 2020 | $1.6B | +6.4% |
| 2019 | $1.5B | +2.3% |
| 2018 | $1.4B | −1.3% |
| 2017 | $1.4B | +4.6% |
| 2016 | $1.4B | −17.8% |
| 2015 | $1.7B | −2.8% |
| 2014 | $1.7B | +1.4% |
| 2013 | $1.7B | −2.3% |
| 2012 | $1.7B | +0.1% |
| 2011 | $1.7B | +5.1% |
| 2010 | $1.7B | −5.1% |
| 2009 | $1.7B | +0.6% |
| 2008 | $1.7B | +7.7% |
| 2007 | $1.6B | — |